Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 34 of 41
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
NCT00818389
Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease
NCT01396603
Zolpidem CR and Hospitalized Patients With Dementia
NCT00814502
Escitalopram Neuroimaging Supplement
NCT01398865
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
NCT00823914
Effect of Vyvanse on Driving in Young Adults With ADHD
NCT00801229
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
NCT00801619
Cognitive Behavioral Therapy for Trichotillomania
NCT00740909
Mallet Finger Splinting Study
NCT01388751
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
NCT00842309
Omega-3 for Peri- and Postmenopausal Depression
NCT00825994
Cognitive-Behavioral Therapy (CBT) in Women Discontinuing Antidepressant for Pregnancy
NCT01453114
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant
NCT00909948
Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy
NCT00910325
Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation
NCT00783952
Proportional Assist Ventilation vs Pressure Support Ventilation
NCT00790725
Autism Spectrum Disorders (ASD) Characterization Study
NCT00801554
Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation
NCT01439594
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
NCT00821080
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT00705926
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
NCT00722800
Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283
Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)
NCT01675414
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
NCT00842868
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
NCT00683852
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
NCT00951028
Internet-Based Depression Screening for College Students
NCT01326793
Effect of Ketamine on Opioid-Induced Hyperalgesia
NCT00833755
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
NCT00759772
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
NCT00955474
Clinical Management of Neuropathic Pain With Ramelteon
NCT00753623
Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma
NCT00722865
Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness
NCT01618227
Neural Correlates of Psychodynamic Psychotherapy for Depression
NCT00812227
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
NCT00771355
Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
NCT00633399
Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
NCT00731653
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
NCT00675506
Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
NCT00720122
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
NCT00824044
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
NCT00920023
The Right Question Project-Mental Health: An Intervention to Increase Engagement and Retention in Mental Health Care
NCT01226329
A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma Patients
NCT00970788
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
NCT00756106
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
NCT00644189
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
NCT00713037
Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery
NCT00694473
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
NCT00694330
The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults
NCT00792207
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.